In Pediatric Cancer Genome Project (PCGP), germline mutations in CPGs were identified in 8.5% of the children and adolescents with cancer; the most commonly mutated genes in the affected patients were TP53, followed by APC, BRCA2, NF1, PMS2, RB1, and RUNX1 [4]. This evidence concerns the gene TP53 and cancer.